NCT00232882View on ClinicalTrials.gov

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Hypertension
Interventions
DRUG

Candesartan Thiazide

Candesartan 16 mg for 4 weeks then added hydrochlorothiazide for 4 weeks

DRUG

Atenolol Thiazide

Atenolol 100 mg for 4 weeks followed by atenolol 100 mg + hydrochlorothiazide 12.5 mg for 4 weeks

DRUG

Thiazide Candesartan

Thiazide 25 mg for 4 weeks then added with Candesartan 16 mg

Trial Locations (1)

H2W 1R7

Institut de Recherches Cliniques de Montréal, Montreal

Sponsors
All Listed Sponsors
collaborator

Ottawa Hospital Research Institute

OTHER

lead

Institut de Recherches Cliniques de Montreal

OTHER